Siliconindia Magazine

Cover Story

Arene Lifesciences: Pioneering API Manufacturer for ARV/HIV with Exports Worldwide

The current scenarios in the pharmaceutical sphere of India portray successful manufacturing of generic drug and formulations; however, the country is heavily dependent on imports for bulk drug intermediates and Active Pharmaceutical Ingredients (APIs). Over 60 percent of APIs and over 80-90 percent of some specific APIs are sourced by India from other nations, reveals a recent research. It is therefore imperative for the Indian pharma industry to focus on increasing investments in R&D and infrastructural facilities to boost the domestic manufacture of APIs and key intermediates at low cost. Also, the Indian government should create a conducive environment and provide incentives to formulation producers to ameliorate the domestic Pharma capabilities...